Best for
Mobile
How to buy Redx Pharma shares | 57p
Own Redx Pharma shares in just a few minutes.
Redx Pharma Plc is a biotechnology business based in the UK. Redx Pharma shares (REDX.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 57p – a decrease of 5% over the previous week. Redx Pharma employs 52 staff and has a trailing 12-month revenue of around £4.3 million.
How to buy shares in Redx Pharma
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: REDX in this case.
- Research Redx Pharma shares. The platform should provide the latest information available.
- Buy your Redx Pharma shares. It's that simple.
What's in this guide?
- Can I buy shares in Redx Pharma?
- Has coronavirus impacted Redx Pharma shares?
- Redx Pharma shares summary
- Compare share dealing platforms
- Is Redx Pharma stock a buy or sell?
- Redx Pharma performance over time
- Redx Pharma's financials
- How volatile are Redx Pharma shares?
- Does Redx Pharma pay a dividend?
- Other common questions
How has Coronavirus impacted Redx Pharma's share price?
Since the stock market crash in March caused by coronavirus, Redx Pharma's share price has had significant positive movement.
Its last market close was 57p, which is 85.53% up on its pre-crash value of 8.25p and 1,166.67% up on the lowest point reached during the March crash when the shares fell as low as 4.5p.
If you had bought £1,000 worth of Redx Pharma shares at the start of February 2020, those shares would have been worth £1,931.03 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £7,862.07.
Redx Pharma share price
Use our graph to track the performance of REDX stocks over time.Redx Pharma shares at a glance
Information last updated 2020-12-27.
| Latest market close | 57p |
|---|---|
| 52-week range | 4.4977p - 76.8207p |
| 50-day moving average | 58.0374p |
| 200-day moving average | 49.3118p |
| Wall St. target price | 65p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -5.2p |
Invest in Redx Pharma shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Redx Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Redx Pharma price performance over time
Historical closes compared with the last close of 55.5p
| 1 month (2020-12-22) | 5.71% |
|---|---|
| 3 months (2020-10-22) | -17.78% |
Redx Pharma financials
| Revenue TTM | £4.3 million |
|---|---|
| Gross profit TTM | £2.8 million |
| Return on assets TTM | -49.22% |
| Return on equity TTM | -212.06% |
| Profit margin | -138.95% |
| Book value | 0.012p |
| Market capitalisation | £158.9 million |
TTM: trailing 12 months
Redx Pharma share dividends
We're not expecting Redx Pharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Redx Pharma share price volatility
Over the last 12 months, Redx Pharma's shares have ranged in value from as little as 4.4977p up to 76.8207p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Redx Pharma's is 0.2444. This would suggest that Redx Pharma's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Redx Pharma overview
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company is developing RXC004, a porcupine inhibitor, which is in Phase I clinical development for the treatment of colorectal, pancreatic, biliary, and gastric cancers, as well as melanoma; ROCK inhibitor for treating inflammatory disease related fibrosis; ROCK2, a Rho-associated protein kinase 2 inhibitor for the treatment of diabetic nephropathy, and idiopathic pulmonary fibrosis (IPF) and non-alcoholic steatohepatitis (NASH)/liver fibrosis; and Porcupine (RXC006), a drug for IPF, NASH, and liver fibrosis. It is also developing Pan-RAF inhibitor for colorectal cancer; SHP2, a protein-tyrosine phosphatase for receptor tyrosine kinase signaling in cancer cells; and RXC005, a reversible inhibitor of Bruton's tyrosine kinase. Redx Pharma Plc has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. The company was founded in 2010 and is based in Macclesfield, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Redx Pharma shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Redx Pharma shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert